BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23427138)

  • 41. The opioid system in alcohol and drug dependence: family-based association study.
    Xuei X; Flury-Wetherill L; Bierut L; Dick D; Nurnberger J; Foroud T; Edenberg HJ
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):877-84. PubMed ID: 17503481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
    Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations.
    Orellana C; Ferreira D; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    Neurodegener Dis; 2016; 16(1-2):77-86. PubMed ID: 26726737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
    Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.
    Wu B; Hand W; Alexov E
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease.
    Hao X; Li C; Du L; Yao X; Yan J; Risacher SL; Saykin AJ; Shen L; Zhang D;
    Sci Rep; 2017 Mar; 7():44272. PubMed ID: 28291242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.
    Randesi M; van den Brink W; Levran O; Blanken P; Butelman ER; Yuferov V; da Rosa JC; Ott J; van Ree JM; Kreek MJ
    Drug Alcohol Depend; 2016 Nov; 168():164-169. PubMed ID: 27664554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
    Jones JD; Luba RR; Vogelman JL; Comer SD
    Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD; Chambers AB; Ott BR; Daiello LA;
    J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide interaction analysis reveals replicated epistatic effects on brain structure.
    Hibar DP; Stein JL; Jahanshad N; Kohannim O; Hua X; Toga AW; McMahon KL; de Zubicaray GI; Martin NG; Wright MJ; ; Weiner MW; Thompson PM
    Neurobiol Aging; 2015 Jan; 36 Suppl 1(0 1):S151-8. PubMed ID: 25264344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.
    Zhang H; Gelernter J; Gruen JR; Kranzler HR; Herman AI; Simen AA
    J Hum Genet; 2010 May; 55(5):278-84. PubMed ID: 20300121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroimaging and genetics in aging and age-related disease.
    Van Horn JD
    Brain Imaging Behav; 2014 Jun; 8(2):141-2. PubMed ID: 24623094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
    Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS
    Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility of brain atrophy to
    Lorenzi M; Altmann A; Gutman B; Wray S; Arber C; Hibar DP; Jahanshad N; Schott JM; Alexander DC; Thompson PM; Ourselin S;
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3162-3167. PubMed ID: 29511103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts.
    Wang ZX; Wang HF; Tan L; Liu J; Wan Y; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jul; 54(5):3181-3188. PubMed ID: 27056075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.